PET Guided Therapy for Early Stage Hodgkin Lymphoma: Are We Positive About a Negative Interim Scan?

Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):12-17. doi: 10.1016/j.ijrobp.2020.02.635. Epub 2020 Mar 4.

Authors

Richard L Bakst¹, Belinda A Campbell², Chelsea C Pinnix³

Affiliations

¹ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: Richard.Bakst@mountsinai.org.
² Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.
³ Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas.

PMID: 32142868
DOI: 10.1016/j.ijrobp.2020.02.635

No abstract available

Publication types

Review
Comment

MeSH terms

Fluorodeoxyglucose F18
Hodgkin Disease*
Humans
Positron-Emission Tomography

Substances

Fluorodeoxyglucose F18